Vitamin B3 treatment for ataxia shows promise in first human trial
(Medical Xpress)—A form of vitamin B3 has shown early promise against Friedreich's ataxia, a debilitating degenerative disease with no treatment or cure, in the first human trial of the treatment involving UCL researchers.
May 2, 2014
0
0